SGHC — SGHC Income Statement
0.000.00%
- $6.77bn
- $6.44bn
- $2.23bn
Annual income statement for SGHC, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,561 | 1,358 | 1,555 | 1,835 | 2,231 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,307 | 1,402 | 1,511 | 1,622 | 1,874 |
| Operating Profit | 254 | -43.8 | 44 | 213 | 357 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 267 | 228 | 20 | 204 | 356 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 279 | 192 | -8 | 123 | 218 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 279 | 191 | -10 | 123 | 217 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 279 | 191 | -10 | 123 | 217 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.463 | 0.618 | 0.06 | 0.294 | 0.51 |
| Dividends per Share | |||||
| Special Dividends per Share |